Spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-[2H]pyran]-3,3',9,13(4'H)-tetrone,22,28-diethyl-5',6'-dihydro-7,11,14,15-tetrahydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,29-octamethyl-,(1R,2'S,5'S,6S,6'S,7R,7E,8S,10R,11R,12S,14R,15S,16R,21E,22R,23E,25S,28S,29R)- (125616-18-4)

Identification
Name:	Spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-[2H]pyran]-3,3',9,13(4'H)-tetrone,22,28-diethyl-5',6'-dihydro-7,11,14,15-tetrahydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,29-octamethyl-,(1R,2'S,5'S,6S,6'S,7R,7E,8S,10R,11R,12S,14R,15S,16R,21E,22R,23E,25S,28S,29R)-
Synonyms:	OligomycinA, 26-demethyl-26-ethyl-28-oxo-;Spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-[2H]pyran]-3,3',9,13(4'H)-tetrone,22,28-diethyl-5',6'-dihydro-7,11,14,15-tetrahydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,29-octamethyl-,(1R,2'S,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-(9CI); Spiro[2,26-dioxabicyclo[23.3.1]nonacosane-27,2'-[2H]pyran], oligomycin Aderiv.; 44-Homooligomycin B; Antibiotic NK 86-0279; NK 86-0279I
CAS:	125616-18-4
Molecular Formula:	C46H74 O12
Molecular Weight:	819.079
InChI:	InChI=1/C46H74O12/c1-12-33-18-16-14-15-17-26(4)43(53)45(11,55)44(54)32(10)41(52)31(9)40(51)30(8)39(50)25(3)19-22-38(49)56-42-29(7)35(21-20-33)57-46(34(42)13-2)37(48)23-27(5)36(58-46)24-28(6)47/h14-16,18-19,22,25-36,39,41-43,47,50,52-53,55H,12-13,17,20-21,23-24H2,1-11H3/b15-14-,18-16-,22-19+/t25-,26+,27-,28+,29?,30-,31-,32-,33-,34-,35-,36-,39+,41-,42+,43-,45+,46+/m0/s1
Molecular Structure:
Properties
Flash Point:	260.6°C
Boiling Point:	918.2°C at 760 mmHg
Density:	1.16g/cm³
Refractive index:	1.545
Flash Point:	260.6°C
Safety Data